You can buy or sell Regeneron and other stocks, options, ETFs, and crypto commission-free!
Regeneron Pharmaceuticals, Inc. Common Stock, also called Regeneron, is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Read More It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Tarrytown, New York
52 Week High
52 Week Low
Barron's Picks And Pans: Facebook, Nokia, Regeneron And More
This weekend's Barron's cover story presents the results from the Barron's 2020 Midyear Roundtable. Other featured articles look how to manage risk in a time o
New York TimesJul 9
These Scientists Raced to Find a Covid-19 Drug. Then the Virus Found Them.
If the trials are successful, company executives have said the treatment could be available by the end of the summer. The hope is that it could serve as a stopg
— per share
Available Aug 5, Pre-Market
The EconomistJul 8
The Economist explains - Can antibody therapies control covid-19?
THIS WEEK an American pharmaceutical company, Regeneron, announced that it had a new drug for covid-19 entering late-stage clinical trials. This is one of sever
Why Regeneron's Stock Is Trading Higher Today
Regeneron Pharmaceuticals (NASDAQ: REGN) shares are trading higher on Tuesday after the company announced it has been awarded a $450 million contract to manufac
Regeneron signs a $450 million contract with the U.S. government for its coronavirus therapy
Regeneron Pharmaceuticals said on Tuesday the U.S. government signed a $450 million contract with the drugmaker to make and supply its potential double-antibody
Stocks making the biggest moves in the premarket: Novavax, Regeneron, Square, Nvidia & more
Take a look at some of the biggest movers in the premarket: Novavax (NVAX) – Novavax was awarded $1.6 billion in funding from "Operation Warp Speed," the gover
U.S. signs $450 million contract with Regeneron for COVID-19 therapy
(Reuters) - The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc (REGN.O) for its potential COVID-19 antibody cocktail, the dru